Strohmeier G R, Lencer W I, Patapoff T W, Thompson L F, Carlson S L, Moe S J, Carnes D K, Mrsny R J, Madara J L
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Clin Invest. 1997 Jun 1;99(11):2588-601. doi: 10.1172/JCI119447.
During active intestinal inflammation polymorphonuclear leukocytes (PMN) transmigrate into the lumen and release 5'-AMP (J. Clin. Invest. 1993. 91:2320-2325). 5'-AMP is converted to adenosine by the apical epithelial surface with subsequent activation of electrogenic Cl- secretion (the basis of secretory diarrhea) via apical A2b adenosine receptors (J. Biol. Chem. 1995. 270:2387-2394). Using a polarized human intestinal epithelial monolayer (T84), we now characterize the basis of the observed conversion of 5'-AMP to adenosine required for this paracrine signaling pathway. An inhibitor of the ecto-5'-nucleotidase CD73, alpha, beta-methylene ADP (AOPCP), inhibited epithelial Cl- secretory responses to 5'-AMP, but not to authentic adenosine. Confocal immunofluorescent microscopy revealed CD73 to be surface expressed on both model and natural human intestinal epithelia. Expression was about sixfold greater on the apical cell surface as assessed biochemically by selective cell surface biotinylation, and morphologically by immunofluorescence. Treatment with phosphotidylinositol specific-phospholipase C (PI-PLC) released 95% of apical CD73, indicating that the intestinal CD73 possesses a glycosylphosphatidylinositol (GPI) anchor. Neither adenosine nor 5'-AMP stimulation induced intact T84 cells to shed surface CD73. The bulk of apical CD73 ( approximately 60%) was released from the cell surface by treatment with 1% Triton X-100 (TX-100) at 4 degrees C, but such release was not affected by pretreatment with ligand or by prior, antibody-mediated cross-linking of CD73. Subsequent analyses showed that the subpool of CD73 released by TX-100 at 4 degrees C was not truly solubilized, but rather represented TX-100-induced release of CD73-containing membrane fragments. These membrane fragments displayed light density on sucrose gradients characteristic of detergent insoluble glycosphingolipid-rich membrane domains (DIGs)/ caveolae, were solubilized by n-octyl glucoside (NOG, 1%) at 4 degrees C, and contained caveolin. These data indicate that human intestinal epithelia express CD73, which is apically polarized and targeted to microdomains with DIGs/caveolae characteristics. CD73 likely participates in translating paracrine, PMN-derived 5'-AMP signals to the authentic effector adenosine. These studies define CD73 as central to PMN-mediated intestinal Cl- secretion, the major directacting mechanism by which PMN induce intestinal epithelial Cl- secretion.
在肠道炎症活跃期,多形核白细胞(PMN)迁移至肠腔并释放5'-AMP(《临床研究杂志》1993年。91:2320 - 2325)。5'-AMP通过顶端上皮表面转化为腺苷,随后经由顶端A2b腺苷受体激活电中性Cl⁻分泌(分泌性腹泻的基础)(《生物化学杂志》1995年。270:2387 - 2394)。利用极化的人肠上皮单层细胞(T84),我们现在确定了这种旁分泌信号通路所需的5'-AMP转化为腺苷这一过程的基础。胞外5'-核苷酸酶CD73的抑制剂α,β-亚甲基ADP(AOPCP)抑制上皮细胞对5'-AMP的Cl⁻分泌反应,但不影响对腺苷的反应。共聚焦免疫荧光显微镜显示CD73在模型和天然人肠上皮细胞表面均有表达。通过选择性细胞表面生物素化进行生化评估以及通过免疫荧光进行形态学评估,发现顶端细胞表面的表达量约高六倍。用磷脂酰肌醇特异性磷脂酶C(PI-PLC)处理可释放95%的顶端CD73,表明肠道CD73具有糖基磷脂酰肌醇(GPI)锚定。腺苷和5'-AMP刺激均未诱导完整的T84细胞脱落表面CD73。大部分顶端CD73(约60%)在4℃用1% Triton X-100(TX-100)处理后从细胞表面释放,但这种释放不受配体预处理或先前抗体介导的CD73交联的影响。随后的分析表明,4℃时TX-100释放的CD73亚群并非真正溶解,而是代表TX-100诱导的含CD73膜片段的释放。这些膜片段在蔗糖梯度上显示出低密度,具有去污剂不溶性富含糖鞘脂的膜结构域(DIGs)/小窝的特征,在4℃用正辛基葡糖苷(NOG,1%)可溶解,并含有小窝蛋白。这些数据表明人肠上皮细胞表达CD73,其在顶端极化并靶向具有DIGs/小窝特征的微结构域。CD73可能参与将旁分泌的、PMN来源的5'-AMP信号转化为真正的效应物腺苷。这些研究将CD73定义为PMN介导的肠道Cl⁻分泌的核心,这是PMN诱导肠上皮Cl⁻分泌的主要直接作用机制。